➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Merck
Boehringer Ingelheim
Express Scripts
Harvard Business School
Colorcon

Last Updated: December 3, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Poloxamer 188

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Poloxamer 188?

Poloxamer 188 is an investigational drug.

There have been 5 clinical trials for Poloxamer 188. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 1997.

The most common disease conditions in clinical trials are Anemia, Sickle Cell, Vascular Diseases, and Peripheral Vascular Diseases. The leading clinical trial sponsors are Mast Therapeutics, Inc., Asan Medical Center, and Valentis.

Recent Clinical Trials for Poloxamer 188
TitleSponsorPhase
Evaluation of Repeat Administration of Purified Poloxamer 188Mast Therapeutics, Inc.Phase 3
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)Mast Therapeutics, Inc.Phase 3
Population Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy VolunteersAsan Medical CenterPhase 1

See all Poloxamer 188 clinical trials

Clinical Trial Summary for Poloxamer 188

Top disease conditions for Poloxamer 188
Top clinical trial sponsors for Poloxamer 188

See all Poloxamer 188 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Merck
Boehringer Ingelheim
Express Scripts
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.